MSN Home  |  My MSN  |  Hotmail
Sign in to Windows Live ID Web Search:   
go to MSNGroups 
Free Forum Hosting
 
Important Announcement Important Announcement
The MSN Groups service will close in February 2009. You can move your group to Multiply, MSN’s partner for online groups. Learn More
The Scientific Debate Forum.Contains "mature" content, but not necessarily adult.[email protected] 
  
What's New
  
  Disclaimer: Read this page first.  
  Links  
  Messages  
  General  
  Nutrition  
  "Mission Statement."  
  Why the "germ theory" is not science.  
  The Underlying Cause of "Disease."  
  The Scientific Method.  
  How dangerous are bacteria and viruses?  
  The Contributions of Hans Selye and others.  
  How direct effects are often ignored, and indirect markers used  
  Understanding "disease" at the molecular level.  
  Understanding disease at the molecular level, part II.  
  What the "common cold" can teach us about illness.  
  The AA connection to today's common "diseases."  
  How easy the key experiments would be to do.  
  The best practical diet and the explanation for it.  
  Fish oil quotes you might want to read  
  Where the "immune system" fits into this view of "disease."  
  How many 'scientific studies' violate the scientific method  
  Why you have to be careful with antioxidants.  
  Why Cancers today are more aggressive than those of the past.  
  The Latest Evidence.  
  Some studies worthy of note.  
  HSWC "in action."  
  How language can impede science.  
  How language impedes science, part II.  
  More on why "germs" don't cause "disease."  
  How a latent virus actually causes "disease."  
  A new report that "says it all."  
  The science "show" must go on?  
  Odds and ends  
  Some thoughts on a book by Robert Gallo.  
  Saturated fatty acids are the solution, not the problem.  
  It's stress, not "germs" that causes disease.  
  Epidemiology: Facts versus "factoids."  
  It's stress, not germs, part II.  
  The latest on "inflammation."  
  Why many nutritional claims make no sense  
  The use of hypotheticals in science.  
  What "viral infections" really do to the body.  
  What determines longevity?  
  An example of an anti-"saturated fat" study that is flawed.  
  A Rough Guide to a Gentle Diet.  
  A unified "AIDS" hypothsis without "HIV."  
  A unified "AIDS" hypothsis without "HIV." Part II.  
  Okay, so when is this diet going to kill me?  
  Scientific Debate Forum Pictures  
  The EFA Claim Was Refuted Long Ago  
    
  
  
  Tools  
 
Nutrition : Arachidonic acid studies of apparent importance.
Choose another message board
View All Messages
  Prev Message  Next Message       
Reply
 Message 55 of 62 in Discussion 
From: MSN Nicknametaka00381  in response to Message 1Sent: 6/7/2008 12:47 PM
J Urol. 2008 May;179(5):1668-75. Epub 2008 Mar 17.

The arachidonic acid pathway and its role in prostate cancer development and progression.

Patel MI, Kurek C, Dong Q.
Department of Surgery, University of Sydney, Westmead, New South Wales, Australia.

PURPOSE: The arachidonic acid pathway incorporates phospholipase, cyclooxygenase, lipoxygenase and epoxygenase enzymes. This pathway has been shown to have a major role in the development and progression of a number of cancers, including prostate cancer. We discuss the current status of research of this pathway in the area of prostate cancer, ranging from preclinical in vitro studies to human clinical trials. MATERIALS AND METHODS: We performed an online search of the current and past peer reviewed literature on prostate cancer and arachidonic acid, phospholipase, cyclooxygenase, lipoxygenase, epoxygenase, platelet activating factor, prostaglandin and eicosanoid. We retrieved and evaluated all full-length articles published in English from the 1980s to January 2007. RESULTS: Epidemiological evidence suggested that nonsteroidal anti-inflammatory drugs may decrease the risk of prostate cancer. This effect, presumably through the inhibition of cyclooxygenase-2, has been validated in preclinical studies. Cyclooxygenase-2 inhibition has also decreased the rate of prostate specific antigen increase in men with biochemical recurrence after treatment for prostate cancer. Although lipoxygenase and secretory phospholipase A2 inhibition was also effective for decreasing prostate cancer growth in preclinical studies, to our knowledge these strategies have not yet been used in clinical trials. Cytosolic phospholipase A2, platelet activating factor and epoxygenase need further investigation to determine a role in prostate cancer. CONCLUSIONS: Evolving data suggest a significant role for some areas of the arachidonic acid pathway in prostate cancer. Inhibiting 1 or a number of these enzymes in combination may hold promise for future prostate cancer treatment.
PMID: 18343442